High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.
作者信息
Roe Kevin
机构信息
San Jose, CA, USA.
出版信息
Transbound Emerg Dis. 2020 Jul;67(4):1418-1421. doi: 10.1111/tbed.13634. Epub 2020 Jun 3.
Abstract
摘要
相似文献
1
High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.
Transbound Emerg Dis. 2020 Jul;67(4):1418-1421. doi: 10.1111/tbed.13634. Epub 2020 Jun 3.
2
Infectious salmon anaemia virus replication and induction of alpha interferon in Atlantic salmon erythrocytes.
Virol J. 2008 Feb 28;5:36. doi: 10.1186/1743-422X-5-36.
3
The use of monoclonal antibodies in (reverse) passive haemagglutination tests for herpes simplex virus antigens and antibodies.
J Med Virol. 1983;11(4):295-306. doi: 10.1002/jmv.1890110405.
4
5
A simplified objective method for quantification of peste des petits ruminants virus or neutralizing antibody.
J Virol Methods. 2000 Sep;89(1-2):89-95. doi: 10.1016/s0166-0934(00)00206-8.
6
A novel rapid direct haemagglutination-inhibition assay for measurements of humoral immune response against non-haemagglutinating strains in vaccinated chickens.
Heliyon. 2017 Oct 31;3(10):e00428. doi: 10.1016/j.heliyon.2017.e00428. eCollection 2017 Oct.
7
Comparison of passive haemagglutination and haemagglutination-inhibition techniques for detection of antibodies to rubella virus.
J Clin Pathol. 1979 Feb;32(2):128-31. doi: 10.1136/jcp.32.2.128.
8
Antigenic relationships of lymphocytic choriomeningitis virus and Tacaribe virus in the indirect haemagglutination test.
Bull World Health Organ. 1975;52(4-6):437-9.
9
The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen.
J Exp Med. 1969 Sep 1;130(3):575-93. doi: 10.1084/jem.130.3.575.
10
Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.
J Gen Virol. 1986 May;67 ( Pt 5):839-50. doi: 10.1099/0022-1317-67-5-839.
引用本文的文献
1
A Comprehensive In Silico Study of New Metabolites from with SARS-CoV-2 Inhibitory Activity.
Molecules. 2022 Oct 29;27(21):7369. doi: 10.3390/molecules27217369.
2
Circulating multimeric immune complexes contribute to immunopathology in COVID-19.
Nat Commun. 2022 Sep 26;13(1):5654. doi: 10.1038/s41467-022-32867-z.
3
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody.
Int J Mol Sci. 2022 Feb 25;23(5):2558. doi: 10.3390/ijms23052558.
4
Prevalence of Symptoms in Patients Discharged from COVID Care Facility of NIMS Hospital: Is RT PCR Negativity Truly Reflecting Recovery? A Single-Centre Observational Study.
Int J Gen Med. 2021 Mar 25;14:1069-1078. doi: 10.2147/IJGM.S295499. eCollection 2021.
5
A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.
Inflammopharmacology. 2020 Oct;28(5):1219-1222. doi: 10.1007/s10787-020-00739-x. Epub 2020 Jul 7.
6
SARS-CoV-2, where to now?
Transbound Emerg Dis. 2020 Jul;67(4):1411-1413. doi: 10.1111/tbed.13654. Epub 2020 Jun 19.
本文引用的文献
1
Explanation for COVID-19 infection neurological damage and reactivations.
Transbound Emerg Dis. 2020 Jul;67(4):1414-1415. doi: 10.1111/tbed.13594. Epub 2020 May 4.
2
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
3
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
Br J Haematol. 2020 Jun;189(5):846-847. doi: 10.1111/bjh.16727. Epub 2020 May 4.
4
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
5
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
6
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
Int J Antimicrob Agents. 2020 May;55(5):105960. doi: 10.1016/j.ijantimicag.2020.105960. Epub 2020 Apr 3.
7
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.
8
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.
J Infect. 2020 May;80(5):e14-e17. doi: 10.1016/j.jinf.2020.03.001. Epub 2020 Mar 20.
9
Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence.
Elife. 2020 Feb 3;9:e48401. doi: 10.7554/eLife.48401.
10
Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins.
Vaccines (Basel). 2019 Nov 1;7(4):169. doi: 10.3390/vaccines7040169.
Zotero 插件